Long COVID Trial, Recruiting NCT07140094 Sponsor: Columbia University Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT07140094
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You are willing and able to sign a consent form agreeing to take part in the study
  • You have access to the internet
  • You have had COVID-19 (confirmed by your own report)
  • You currently have symptoms that you or your doctor believe are related to Long COVID, and these symptoms have lasted for 12 weeks or more after your COVID-19 illness

Who may not be able to join:

  • You are currently taking part in another clinical trial that is testing a treatment for Long COVID symptoms
  • You are currently taking part in a structured mind-body program (such as a formal meditation, mindfulness, or stress-reduction program) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Deborah Theodore, MD, Columbia University

Phone: 2123058739

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 May 2024
Est. completion
21 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean Score of Patient-Reported Outcomes Measurement Information System (PROMIS) Global 10 Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov